Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
242 hedge funds and large institutions have $3.13B invested in Cantel Medical Corporation in 2019 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 87 increasing their positions, 87 reducing their positions, and 38 closing their positions.
201% more call options, than puts
Call options by funds: $6.58M | Put options by funds: $2.19M
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
27% more capital invested
Capital invested by funds: $2.47B → $3.13B (+$664M)
0% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 87
5% less funds holding
Funds holding: 254 → 242 (-12)
21% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$84.2M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$32.1M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$25.7M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$25.1M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Impax Asset Management Group
London,
United Kingdom
|
-$32.1M |
| 2 |
Los Angeles Capital Management
Los Angeles,
California
|
-$21M |
| 3 |
FAM
Fred Alger Management
New York
|
-$12.7M |
| 4 |
Royal London Asset Management
United Kingdom
|
-$9.97M |
| 5 |
SCA
Summit Creek Advisors
Minneapolis,
Minnesota
|
-$5.05M |
CMD Hedge Fund Activity: Q2 2019 in Review
242 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2019, worth a combined $3.13B — up 27% from $2.47B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CMD and 30 opened new positions — a net loss of 8 holders — while 87 trimmed existing stakes and 87 added.
The largest buyer was Janus Henderson Group, adding an estimated $84.2M. The largest seller was Impax Asset Management Group, exiting entirely with an estimated $32.1M sold.
- 242 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2019, down from 254 in Q1 2019.
- Funds reported $3.13B of Cantel Medical Corporation stock for Q2 2019, up 27% quarter-over-quarter.
- 30 funds opened new Cantel Medical Corporation positions in Q2 2019 and 38 closed out, a net change of -8 holders.
- The largest Cantel Medical Corporation buyer in Q2 2019 was Janus Henderson Group, an estimated $84.2M added.
- The largest Cantel Medical Corporation seller in Q2 2019 was Impax Asset Management Group, an estimated $32.1M sold.
Based on aggregated 13F filings for Q2 2019.